Gemzar (gemcitabine)

Approved for Pancreatic adenocarcinoma, Non-small cell lung cancer, Breast cancer. Converted intracellularly to active diphosphate and triphosphate nucleotides. The diphosphate inhibits ribonucleotide reductase, reducing deoxynucleotide pools. The triphosphate is incorporated into… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS,…

Loading full data from Know Your Drugs Institute…